Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Biotech-bay crawled time : 22:00 save search
Arcellx to Participate in the 23rd Annual Needham Virtual Healthcare Conference
Published: 2024-04-04 (Crawled : 22:00) - biospace.com/
ACLX | $52.0 0.68% 0.67% 440K
|
|
| O: -0.13%
H: 2.16%
C: -1.76%
conference
Alto Neuroscience Reports Full Year 2023 Financial Results and Recent Business Highlights
Published: 2024-03-21 (Crawled : 22:00) - biospace.com/
JNJ | News | $149.12 0.82% 0.59% 440K
|
Health Technology
|
| O: -0.03%
H: 0.0%
C: 0.0%
business year financial results
Protagonist Reports Third Quarter 2023 Financial Results and Provides Corporate Update
Published: 2023-11-02 (Crawled : 22:00) - biospace.com/
PTGX S | $26.61 3.91% 3.72% 300K
|
Health Technology
|
| O: 2.05%
H: 0.78%
C: -0.06%
update financial results
Mirum Pharmaceuticals Reports Third Quarter 2023 Financial Results and Provides Business Update
Published: 2023-11-02 (Crawled : 22:00) - biospace.com/
MIRM | $24.17 1.51% 1.49% 250K
|
Health Technology
|
| O: 0.28%
H: 1.3%
C: -0.39%
business update pharmaceuticals financial results
CareDx to Report Third Quarter 2023 Financial Results
Published: 2023-11-02 (Crawled : 22:00) - biospace.com/
CDNA | $8.17 -1.69% -1.71% 480K
|
Health Technology
|
| O: 15.34%
H: 5.61%
C: -4.65%
report financial results
Sangamo Therapeutics Announces Strategic Update and Reports Third Quarter 2023 Financial Results
Published: 2023-11-01 (Crawled : 22:00) - biospace.com/
SGMO | News | $0.5101 -0.27% 0.7% 1.3M
|
Health Technology
|
| O: 3.14%
H: 1.54%
C: -9.11%
update therapeutics financial results
Nevro Reports Third Quarter 2023 Financial Results, Provides Fourth Quarter Guidance and Updates Full-Year 2023 Guidance
Published: 2023-11-01 (Crawled : 22:00) - biospace.com/
NVRO | $12.27 1.66% 0.0% 580K
|
Health Technology
|
| O: -0.21%
H: 1.53%
C: 1.39%
financial
Nurix Therapeutics Announces Partial Clinical Hold For NX-2127 Phase 1 TrialCurrently enrolled patients may continue receiving NX-2127
Published: 2023-11-01 (Crawled : 22:00) - biospace.com/
NRIX 6 d | $13.58 -0.07% -0.07% 0
|
Health Technology
|
| O: 0.54%
H: 2.31%
C: 0.71%
nx-2127 therapeutics
Sangamo Therapeutics Announces Third Quarter 2023 Conference Call and Webcast
Published: 2023-10-25 (Crawled : 22:00) - biospace.com/
SGMO | News | $0.5101 -0.27% 0.7% 1.3M
|
Health Technology
|
| O: 2.39%
H: 4.59%
C: -3.46%
conference therapeutics
CARGO Therapeutics Announces Appointment of Ginna Laport, MD, as Chief Medical Officer
Published: 2023-10-17 (Crawled : 22:00) - biospace.com/
CRGX | $19.03 -0.83% -0.68% 20
|
| Email alert
Add to watchlist
medical therapeutics
Mirum Pharmaceuticals Announces New PDUFA Date for LIVMARLI for the Treatment of Cholestatic Pruritus in Progressive Familial Intrahepatic Cholestasis
Published: 2023-10-17 (Crawled : 22:00) - biospace.com/
MIRM | $24.17 1.51% 1.49% 250K
|
Health Technology
|
| O: 1.36%
H: 4.07%
C: 2.26%
pruritus treatment pharmaceuticals pdufa livmarli
Guardant Health to Report Third Quarter 2023 Financial Results on November 6, 2023
Published: 2023-10-16 (Crawled : 22:00) - biospace.com/
GH | News M | $17.59 9.46% 8.59% 660
|
Health Services
|
| O: -0.15%
H: 4.22%
C: 2.37%
report health financial results
HI-Bio to Present at the American Society of Nephrology Kidney Week 2023 Annual Meeting
Published: 2023-10-13 (Crawled : 22:00) - biospace.com/
IMAB | $1.8 0.0% 0
|
Health Technology
|
| O: -1.49%
H: 5.68%
C: 1.52%
kidney meeting week
New Data from Phase 3 Trial Further Validate Prognostic Value of Veracyte’s Decipher Prostate Genomic Classifier
Published: 2023-10-04 (Crawled : 22:00) - biospace.com/
VCYT | News | $19.85 2.06% 2.02% 650K
|
Health Technology
|
| O: 0.56%
H: 0.6%
C: -0.46%
genomic trial
Sangamo Therapeutics to Present at the Jefferies Cell & Genetic Medicine Summit
Published: 2023-09-20 (Crawled : 22:00) - biospace.com/
SGMO | News | $0.5101 -0.27% 0.7% 1.3M
|
Health Technology
|
| O: -0.52%
H: 4.98%
C: 0.05%
genetic cell therapeutics
Pulse Biosciences to Present at Gilmartin Group Emerging Growth Showcase
Published: 2023-09-07 (Crawled : 22:00) - biospace.com/
PLSE | $6.85 -4.73% -4.96% 94K
|
Health Technology
|
| O: -0.83%
H: 0.0%
C: -1.04%
group growth
CymaBay's Seladelpar Achieves High Statistical Significance for the Primary and Key Secondary Endpoints in the Phase 3 RESPONSE Trial in Primary Biliary Cholangitis
Published: 2023-09-07 (Crawled : 22:00) - biospace.com/
CBAY | $32.48 0.03% 8.4M
|
Health Technology
|
| O: 14.92%
H: 0.19%
C: -5.42%
trial response
Guardant Health Provides Update on COBRA Study, Restates Confidence in MRD Test
Published: 2023-09-01 (Crawled : 22:00) - biospace.com/
GH | News M | $17.59 9.46% 8.59% 660
|
Health Services
|
| O: 1.15%
H: 2.4%
C: -11.43%
test health update
Atara Biotherapeutics to Participate in Cell Therapies in Autoimmune Panel Discussion at the Citi 18th Annual BioPharma Conference
Published: 2023-08-31 (Crawled : 22:00) - biospace.com/
ATRA | $0.6974 5.51% 4.8% 55
|
Health Technology
|
| O: -0.68%
H: 6.21%
C: 0.69%
conference cell biopharma
Guardant Health to Participate in the Morgan Stanley 21st Annual Global Healthcare Conference
Published: 2023-08-31 (Crawled : 22:00) - biospace.com/
MS | News 0 d | $92.09 1.58% 0.12% 2.9K
|
Finance
|
| O: -0.29%
H: 0.0%
C: 0.0%
GH | News M | $17.59 9.46% 8.59% 660
|
Health Services
|
| O: 0.08%
H: 0.97%
C: -2.3%
conference health global
Gainers vs Losers
| 72% | 28% |
Top 10 Gainers
AGBA | $2.5 100.0% 58.33% 200M
|
Finance
EDBL | News | $6.26 66.49% 48.56% 270K
|
MLEC | $2.47 76.43% 38.05% 460K
|
n/a
PEGY | $0.0458 -10.2% 28.77% 79M
|
Manufacturing
PALI | $4.93 4.67% 25.83% 2.1M
|
Manufacturing
SILO | $1.99 0.71% 20.64% 1.8M
|
Finance and Insurance
NNVC | $1.12 1.82% 19.64% 2.5K
|
Health Technology
CANG | $1.34 -4.29% 14.93% 120K
|
Technology Services
AZTR 4 | $0.195 13.85% 42K
|
n/a
TOVX | News | $0.411 -1.01% 12.9% 230K
|
Manufacturing
Your saved searches
Save your searches and get alerts when important news are released.